No price history available.
Key financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | INRm | 7,194 | 6,500 | 9,738 | 11,736 | 12,969 | 15,159 | 17,031 | N/A | N/A |
| Operating profit | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | INRm | 557 | 400 | 1,383 | 2,108 | 2,170 | 2,434 | 2,783 | N/A | N/A |
| EPS reported | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Value | ||||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | ||||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | ||||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | ||||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Rainbow Children's Medicare Limited is a leading Indian healthcare provider managing a network of multi-specialty hospitals dedicated to pediatric, obstetrics, and gynecology services. Its comprehensive child health offerings include general pediatrics, neonatology, various surgical disciplines, gastroenterology, hematology, oncology, psychology, dentistry, pulmonology, endocrinology, nephrology, nutrition, and psychiatric support. The company also delivers specialized care such as intensive care units, bone marrow and kidney transplants, cochlear implants, genetic and metabolic medicine, and therapeutic services like speech, language, and occupational therapy, alongside developmental and behavioral pediatrics. For women's health, Rainbow provides extensive obstetrics and gynecology services, including high-risk pregnancy management, painless delivery options, childbirth education, post-delivery support, well-woman check-ups, urogynecology, pre-pregnancy assessments, minimally invasive surgery, breast care, fetal medicine, and menopausal treatments. Furthermore, the company offers a full spectrum of fertility solutions, encompassing ovulation induction, various in-vitro fertilization techniques (such as ICSI and IMSI), intrauterine insemination, assisted hatching, cryopreservation, donor programs (sperm, oocyte, embryo), surgical sperm retrieval, and reproductive surgery. As of December 31, 2021, the company operated 14 hospitals and 3 clinics across 6 cities, providing a total of 1,500 beds. Established in 1998, its headquarters are situated in Hyderabad, India.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Rainbow Children's Medicare Limited (RAINBOW.NS)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Rainbow Children's Medicare Limited is a leading Indian healthcare provider managing a network of multi-specialty hospitals dedicated to pediatric, obstetrics, and gynecology services. Its comprehensive child health offerings include general pediatrics, neonatology, various surgical disciplines, gastroenterology, hematology, oncology, psychology, dentistry, pulmonology, endocrinology, nephrology, nutrition, and psychiatric support. The company also delivers specialized care such as intensive care units, bone marrow and kidney transplants, cochlear implants, genetic and metabolic medicine, and therapeutic services like speech, language, and occupational therapy, alongside developmental and behavioral pediatrics. For women's health, Rainbow provides extensive obstetrics and gynecology services, including high-risk pregnancy management, painless delivery options, childbirth education, post-delivery support, well-woman check-ups, urogynecology, pre-pregnancy assessments, minimally invasive surgery, breast care, fetal medicine, and menopausal treatments. Furthermore, the company offers a full spectrum of fertility solutions, encompassing ovulation induction, various in-vitro fertilization techniques (such as ICSI and IMSI), intrauterine insemination, assisted hatching, cryopreservation, donor programs (sperm, oocyte, embryo), surgical sperm retrieval, and reproductive surgery. As of December 31, 2021, the company operated 14 hospitals and 3 clinics across 6 cities, providing a total of 1,500 beds. Established in 1998, its headquarters are situated in Hyderabad, India.
